These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9864154

  • 1. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
    Taksin AL, Couedic JP, Dusanter-Fourt I, Massé A, Giraudier S, Katz A, Wendling F, Vainchenker W, Casadevall N, Debili N.
    Blood; 1999 Jan 01; 93(1):125-39. PubMed ID: 9864154
    [Abstract] [Full Text] [Related]

  • 2. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.
    Hofmann WK, Kalina U, Wagner S, Seipelt G, Ries C, Hoelzer D, Ottmann OG.
    Exp Hematol; 1999 Mar 01; 27(3):395-400. PubMed ID: 10089900
    [Abstract] [Full Text] [Related]

  • 3. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders.
    Li Y, Hetet G, Kiladjian JJ, Gardin C, Grandchamp B, Briere J.
    Br J Haematol; 1996 Jan 01; 92(1):60-6. PubMed ID: 8562412
    [Abstract] [Full Text] [Related]

  • 4. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.
    Letestu R, Vitrat N, Massé A, Le Couedic JP, Lazar V, Rameau P, Wendling F, Vuillier J, Boutard P, Plouvier E, Plasse M, Favier R, Vainchenker W, Debili N.
    Blood; 2000 Mar 01; 95(5):1633-41. PubMed ID: 10688818
    [Abstract] [Full Text] [Related]

  • 5. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
    Vitrat N, Cohen-Solal K, Norol F, Guichard J, Cramer E, Vainchenker W, Wendling F, Debili N.
    Stem Cells; 1998 Mar 01; 16 Suppl 2():37-51. PubMed ID: 11012176
    [Abstract] [Full Text] [Related]

  • 6. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia.
    Yan L, Elkassar N, Gardin C, Briere J.
    Leuk Lymphoma; 1996 Sep 01; 22 Suppl 1():31-40. PubMed ID: 8951770
    [Abstract] [Full Text] [Related]

  • 7. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.
    Glembotsky AC, Korin L, Lev PR, Chazarreta CD, Marta RF, Molinas FC, Heller PG.
    Eur J Haematol; 2010 May 01; 84(5):398-405. PubMed ID: 20113333
    [Abstract] [Full Text] [Related]

  • 8. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets.
    Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R.
    Blood; 1995 Jan 15; 85(2):391-401. PubMed ID: 7529061
    [Abstract] [Full Text] [Related]

  • 9. Myelofibrosis: experimental models and human studies.
    Taskin AL, Cohen-Solal K, Le Couedic JP, Abina MA, Villeval JL, Debili N, Casadevall N, Vainchenker W, Wendling F.
    Stem Cells; 1998 Jan 15; 16 Suppl 2():155-64. PubMed ID: 11012187
    [Abstract] [Full Text] [Related]

  • 10. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
    Catani L, Gugliotta L, Campanini E, Mangianti S, Gibellini D, Baravelli S, Vianelli N, Lemoli RM, Tura S.
    Br J Haematol; 1998 Jan 15; 100(1):207-18. PubMed ID: 9450813
    [Abstract] [Full Text] [Related]

  • 11. Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes.
    Alvarez-Larran A, Martínez D, Arenillas L, Rubio A, Arellano-Rodrigo E, Hernández Boluda JC, Papaleo N, Caballero G, Martínez C, Ferrer-Marín F, Mata MI, Pérez-Encinas M, Durán MA, Alonso JM, Carreño-Tarragona G, Alonso JM, Noya S, Magro E, Pérez R, López-Guerra M, Pastor-Galán I, Cervantes F, Besses C, Colomo L, Rozman M.
    J Clin Pathol; 2018 Nov 15; 71(11):975-980. PubMed ID: 29934356
    [Abstract] [Full Text] [Related]

  • 12. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
    Kalina U, Hofmann WK, Koschmieder S, Wagner S, Kauschat D, Hoelzer D, Ottmann OG.
    Exp Hematol; 2000 Oct 15; 28(10):1158-63. PubMed ID: 11027834
    [Abstract] [Full Text] [Related]

  • 13. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
    Debili N, Wendling F, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W.
    Blood; 1995 Oct 01; 86(7):2516-25. PubMed ID: 7545460
    [Abstract] [Full Text] [Related]

  • 14. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, Galinsky I, DeAngelo DJ, Clark JJ, Lee SJ, Golub TR, Wadleigh M, Gilliland DG, Levine RL.
    PLoS Med; 2006 Jul 01; 3(7):e270. PubMed ID: 16834459
    [Abstract] [Full Text] [Related]

  • 15. Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow.
    Wang JC, Hashmi G.
    Leuk Res; 2003 Jan 01; 27(1):13-7. PubMed ID: 12479847
    [Abstract] [Full Text] [Related]

  • 16. Analysis of thrombopoietin and c-mpl expression in a child with essential thrombocythemia.
    Yoshida N, Ishii E, Koga N, Kamimura T, Miyazaki S.
    Pediatr Hematol Oncol; 1998 Jan 01; 15(4):359-63. PubMed ID: 9658438
    [Abstract] [Full Text] [Related]

  • 17. Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis.
    Chaligné R, James C, Tonetti C, Besancenot R, Le Couédic JP, Fava F, Mazurier F, Godin I, Maloum K, Larbret F, Lécluse Y, Vainchenker W, Giraudier S.
    Blood; 2007 Nov 15; 110(10):3735-43. PubMed ID: 17709604
    [Abstract] [Full Text] [Related]

  • 18. Effects of cytokines on platelet production from blood and marrow CD34+ cells.
    Norol F, Vitrat N, Cramer E, Guichard J, Burstein SA, Vainchenker W, Debili N.
    Blood; 1998 Feb 01; 91(3):830-43. PubMed ID: 9446643
    [Abstract] [Full Text] [Related]

  • 19. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
    Griesshammer M, Bangerter M, Schrezenmeier H.
    Semin Thromb Hemost; 1997 Feb 01; 23(5):419-23. PubMed ID: 9387200
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
    Goncalves F, Lacout C, Féger F, Cohen-Solal K, Guichard J, Cramer E, Vainchenker W, Duménil D.
    Leukemia; 1998 Sep 01; 12(9):1355-66. PubMed ID: 9737683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.